This is an open-label study to evaluate the safety, tolerability, and immunogenicity of dose combinations of INO-1800 (DNA plasmids encoding HBsAg and HBcAg) and INO-9112 (DNA plasmid encoding human interleukin 12) delivered by electroporation (EP) in 90 (ninety) nucleos(t)ide analogue treated patients.https://clinicaltrials.gov/show/NCT02431312 作者: MP4 时间: 2017-6-14 11:46